Fresh off its biggest deal yet, Organigram Holdings (Nasdaq: OGI) is now refocusing its attention beyond Canada’s borders. The cannabis producer’s executives painted an ambitious picture during Wednesday’s earnings call, detailing plans to dive deeper into Germany’s medical market while squeezing more value from their recent Motif Labs purchase. “There’s …